메뉴 건너뛰기




Volumn 51, Issue 11, 2010, Pages 2012-2020

Quality of life of long-term survivors with Hodgkin lymphoma after high-dose chemotherapy, autologous stem cell transplantation, and conventional chemotherapy

Author keywords

Chemotherapy; High dose therapy; Hodgkin lymphoma; Quality of life

Indexed keywords

BLEOMYCIN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; MELPHALAN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

EID: 78649274520     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2010.513749     Document Type: Article
Times cited : (24)

References (46)
  • 1
    • 0036049779 scopus 로고    scopus 로고
    • High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish lymphoma research group
    • Czyz J, Hellmann A, Dziadziuszko R, et al. High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research Group. Bone Marrow Transpl 2002;30:29-34.
    • (2002) Bone Marrow Transpl , vol.30 , pp. 29-34
    • Czyz, J.1    Hellmann, A.2    Dziadziuszko, R.3
  • 2
    • 0032895067 scopus 로고    scopus 로고
    • Comparison of highdose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure
    • André M, Henry-Amar M, Pico JL, et al. Comparison of highdose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure. J Clin Oncology 1999;17:222-229.
    • (1999) J. Clin. Oncology , vol.17 , pp. 222-229
    • André, M.1    Henry-Amar, M.2    Pico, J.L.3
  • 3
    • 34548599996 scopus 로고    scopus 로고
    • High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: Prognostic features and outcomes
    • Engelhardt BG, Holland DW, Brandt SJ, et al. High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: prognostic features and outcomes. Leuk Lymphoma 2007;48:1728-1735.
    • (2007) Leuk Lymphoma , vol.48 , pp. 1728-1735
    • Engelhardt, B.G.1    Holland, D.W.2    Brandt, S.J.3
  • 4
    • 23744515284 scopus 로고    scopus 로고
    • High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: Long-term outcome in the first 100 patients treated in Vancouver
    • Lavoie JC, Connors JM, Phillips GL, et al. High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver. Blood 2005;106:1473-1478.
    • (2005) Blood , vol.106 , pp. 1473-1478
    • Lavoie, J.C.1    Connors, J.M.2    Phillips, G.L.3
  • 5
    • 46249110117 scopus 로고    scopus 로고
    • Long-term outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma
    • Sirohi B, Cunningham D, Powels R, et al. Long-term outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma. Ann Oncology 2008;19:1312-1319.
    • (2008) Ann. Oncology , vol.19 , pp. 1312-1319
    • Sirohi, B.1    Cunningham, D.2    Powels, R.3
  • 6
    • 40449086384 scopus 로고    scopus 로고
    • Managing relapsed and refractory Hodgkin Lymphoma
    • Brice P. Managing relapsed and refractory Hodgkin Lymphoma. Br J Haematol 2008;141:3-13.
    • (2008) Br. J. Haematol. , vol.141 , pp. 3-13
    • Brice, P.1
  • 7
    • 0027534424 scopus 로고
    • The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-centre eight-year study of 155 patients
    • Chopra R, McMillan AK, Linch DC, et al. The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-centre eight-year study of 155 patients. Blood 1993;81:1137-1145.
    • (1993) Blood , vol.81 , pp. 1137-1145
    • Chopra, R.1    McMillan, A.K.2    Linch, D.C.3
  • 8
    • 0027374883 scopus 로고
    • High-dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: Long term follow-up in 128 patients
    • Bierman PJ, Bagin RG, Jagannath S, et al. High-dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: long term follow-up in 128 patients. Ann Oncol 1993;4:767-773.
    • (1993) Ann. Oncol. , vol.4 , pp. 767-773
    • Bierman, P.J.1    Bagin, R.G.2    Jagannath, S.3
  • 9
    • 0037097044 scopus 로고    scopus 로고
    • Aggressive conventional chemotherapy compared with high-dose chemotherapy with ASCT for relapsed chemosensitive Hodgkin's disease: A randomized trial
    • Schmitz N, Pfistner B, Sextro M, et al. Aggressive conventional chemotherapy compared with high-dose chemotherapy with ASCT for relapsed chemosensitive Hodgkin's disease: a randomized trial. Lancet 2002;359:2065-2071.
    • (2002) Lancet , vol.359 , pp. 2065-2071
    • Schmitz, N.1    Pfistner, B.2    Sextro, M.3
  • 10
    • 0027404777 scopus 로고
    • Dose intensification in autologous bone marrow transplantation in relapsed and resistant Hodgkin's disease: Results of a BNLI randomized trial
    • Linch DC, Winfeld D, Goldstone AH, et al. Dose intensification in autologous bone marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomized trial. Lancet 1993;341:1051-1054.
    • (1993) Lancet , vol.341 , pp. 1051-1054
    • Linch, D.C.1    Winfeld, D.2    Goldstone, A.H.3
  • 11
    • 0028008639 scopus 로고
    • The quality of life of long-term survivors of Hodgkin's disease
    • Van Tulder MW, Aaronson NK, Bruning PF. The quality of life of long-term survivors of Hodgkin's disease. Ann Oncol 1994;5:153-158.
    • (1994) Ann. Oncol. , vol.5 , pp. 153-158
    • Van Tulder, M.W.1    Aaronson, N.K.2    Bruning, P.F.3
  • 12
    • 0142026057 scopus 로고    scopus 로고
    • Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest oncology group study 9133
    • Ganz PA, Moinpour CM, Pauler DK, et al. Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133. J Clin Oncol 2003;21:3512-3519.
    • (2003) J. Clin. Oncol. , vol.21 , pp. 3512-3519
    • Ganz, P.A.1    Moinpour, C.M.2    Pauler, D.K.3
  • 13
    • 0033053928 scopus 로고    scopus 로고
    • Reduced health-related quality of life among Hodgkin's disease survivors: A comparative study with general population norms
    • Loge JH, Foss Abrahamsen A, Ekeberg O, Kaasa S. Reduced health-related quality of life among Hodgkin's disease survivors: a comparative study with general population norms. Ann Oncology 1999;10:71-77.
    • (1999) Ann. Oncology , vol.10 , pp. 71-77
    • Loge, J.H.1    Abrahamsen, A.F.2    Ekeberg, O.3    Kaasa, S.4
  • 14
    • 0042856372 scopus 로고    scopus 로고
    • Individual quality of life in long-term survivors of Hodgkin's lymphoma - A comparative study
    • Wettergren L, Björkholm M, Axdorph U, Bowling A, Langius-Eklöf A. Individual quality of life in long-term survivors of Hodgkin's lymphoma - a comparative study. Qual Life Res 2003;12:545-554.
    • (2003) Qual. Life Res. , vol.12 , pp. 545-554
    • Wettergren, L.1    Björkholm, M.2    Axdorph, U.3    Bowling, A.4    Langius-Eklöf, A.5
  • 15
    • 0142027971 scopus 로고    scopus 로고
    • Fatigue in long-term survivors of Hodgkin's lymphoma; a report from the German hodgkin lymphoma study group (GHSG)
    • Ruffer JU, Flechtner H, Tralls P, et al. Fatigue in long-term survivors of Hodgkin's lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG). Eur J Cancer 2003;39:2179-2186.
    • (2003) Eur. J. Cancer , vol.39 , pp. 2179-2186
    • Ruffer, J.U.1    Flechtner, H.2    Tralls, P.3
  • 16
    • 27244437082 scopus 로고    scopus 로고
    • Fatigue in longterm Hodgkin's disease survivors: A follow-up study
    • Hjermstad MJ, Fossa SD, Oldervoll L, et al. Fatigue in longterm Hodgkin's disease survivors: a follow-up study. J Clin Oncol 2005;23:6587-6595.
    • (2005) J. Clin. Oncol. , vol.23 , pp. 6587-6595
    • Hjermstad, M.J.1    Fossa, S.D.2    Oldervoll, L.3
  • 17
    • 0033783428 scopus 로고    scopus 로고
    • High-dose therapy with peripheral blood stem cell transplantation for patients with relapsed or refractory Hodgkin's disease: Long-term outcome and prognostic factors
    • Neben K, Hohaus S, Goldschmidt H, et al. High-dose therapy with peripheral blood stem cell transplantation for patients with relapsed or refractory Hodgkin's disease: long-term outcome and prognostic factors. Ann Hematol 2000;79:547-555.
    • (2000) Ann. Hematol. , vol.79 , pp. 547-555
    • Neben, K.1    Hohaus, S.2    Goldschmidt, H.3
  • 18
    • 17144379311 scopus 로고    scopus 로고
    • Health status of the German population: Results of a representative survey using the EuroQol questionnaire
    • König HH, Bernert S, Angermeyer MC. Health status of the German population: results of a representative survey using the EuroQol questionnaire. Gesundheitswesen 2000;67:173-182.
    • (2000) Gesundheitswesen , vol.67 , pp. 173-182
    • König, H.H.1    Bernert, S.2    Angermeyer, M.C.3
  • 19
    • 0034955552 scopus 로고    scopus 로고
    • Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population
    • Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 2001;37:1345-1351.
    • (2001) Eur. J. Cancer , vol.37 , pp. 1345-1351
    • Schwarz, R.1    Hinz, A.2
  • 22
    • 0036176029 scopus 로고    scopus 로고
    • A quality of life research within the EORTC - The EORTC QLQ-C30
    • Fayers P, Bottomley. A quality of life research within the EORTC - the EORTC QLQ-C30. Eur J Cancer 2005;38:125-133.
    • (2005) Eur. J. Cancer , vol.38 , pp. 125-133
    • Fayers, P.1    Bottomley2
  • 23
    • 0027417437 scopus 로고
    • The European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology
    • Aaronson NK, Ahmedzai S, Bergman B, et al. The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-376.
    • (1993) J. Natl. Cancer Inst. , vol.85 , pp. 365-376
    • Aaronson, N.K.1    Ahmedzai, S.2    Bergman, B.3
  • 25
    • 1342347868 scopus 로고    scopus 로고
    • Individual quality of life of patients undergoing autologous peripheral blood stem cell transplantation
    • Frick E, Borasio GD, Zehentner H, Fischer N, Bumeder I. Individual quality of life of patients undergoing autologous peripheral blood stem cell transplantation. Psychooncology 2004;13:116-124.
    • (2004) Psychooncology , vol.13 , pp. 116-124
    • Frick, E.1    Borasio, G.D.2    Zehentner, H.3    Fischer, N.4    Bumeder, I.5
  • 26
    • 0041866261 scopus 로고    scopus 로고
    • Quality of life immediately after peripheral blood stem cell transplantation
    • Hacker ED, Ferrans CE. Quality of life immediately after peripheral blood stem cell transplantation. Cancer Nurs 2003;26:312-322.
    • (2003) Cancer Nurs. , vol.26 , pp. 312-322
    • Hacker, E.D.1    Ferrans, C.E.2
  • 27
    • 41949101010 scopus 로고    scopus 로고
    • Quality of life before and one year following stem cell transplantation using an individualized and a standardized instrument
    • Wettergren L, Sprangers M, Björkholm M, Langius-Eklöf A. Quality of life before and one year following stem cell transplantation using an individualized and a standardized instrument. Psychooncology 2008;1:338-346.
    • (2008) Psychooncology , vol.1 , pp. 338-346
    • Wettergren, L.1    Sprangers, M.2    Björkholm, M.3    Langius-Eklöf, A.4
  • 28
    • 36549080513 scopus 로고    scopus 로고
    • BEAC or BEAM highdose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin lymphoma patients: Comparative analysis of efficacy and toxicity
    • Jo JC, Kang BW, Jang G, et al. BEAC or BEAM highdose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin lymphoma patients: comparative analysis of efficacy and toxicity. Ann Oncology 2008;87:43-48.
    • (2008) Ann. Oncology , vol.87 , pp. 43-48
    • Jo, J.C.1    Kang, B.W.2    Jang, G.3
  • 29
    • 33748526486 scopus 로고    scopus 로고
    • Morbidity and transplant-related mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantation
    • Puig N, De la Rubia J, Remigia MJ, et al. Morbidity and transplant-related mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantation. Leuk Lymphoma 2006;47:1488-1494.
    • (2006) Leuk Lymphoma , vol.47 , pp. 1488-1494
    • Puig, N.1    De La Rubia, J.2    Remigia, M.J.3
  • 30
    • 0031451082 scopus 로고    scopus 로고
    • Pulmonary toxicity of high-dose chemotherapy for breast cancer: A non-invasive approach to diagnosis and treatment
    • Chap L, Shpiner R, Levine M, Norton L, Lill M, Glaspy J. Pulmonary toxicity of high-dose chemotherapy for breast cancer: a non-invasive approach to diagnosis and treatment. Bone Marrow Transplant 1997;20:1063-1067.
    • (1997) Bone Marrow Transplant. , vol.20 , pp. 1063-1067
    • Chap, L.1    Shpiner, R.2    Levine, M.3    Norton, L.4    Lill, M.5    Glaspy, J.6
  • 31
    • 0034571547 scopus 로고    scopus 로고
    • Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma
    • Johnston LJ, Stockerl-Goldstein KE, Hu WW, et al. Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma. Biol Blood Marrow Transplant 2000;6:555-562.
    • (2000) Biol. Blood Marrow Transplant. , vol.6 , pp. 555-562
    • Johnston, L.J.1    Stockerl-Goldstein, K.E.2    Hu, W.W.3
  • 32
    • 23744506484 scopus 로고    scopus 로고
    • A longitudinal prospective study of healthrelated quality of life in breast cancer patients following highdose chemotherapy with autologous blood stem cell transplantation
    • Conner-Spady BL, Cumming C, Nabholtz JM, Jacobs P, Stewart D. A longitudinal prospective study of healthrelated quality of life in breast cancer patients following highdose chemotherapy with autologous blood stem cell transplantation. Bone Marrow Transplant 2005;36:251-259.
    • (2005) Bone Marrow Transplant. , vol.36 , pp. 251-259
    • Conner-Spady, B.L.1    Cumming, C.2    Nabholtz, J.M.3    Jacobs, P.4    Stewart, D.5
  • 33
    • 26444477289 scopus 로고    scopus 로고
    • Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: Results from cancer and leukemia group B 9066
    • Peppercorn J, Herndon J IInd, Kornblith AB, et al. Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066. Cancer 2005;104:1580-1589.
    • (2005) Cancer , vol.104 , pp. 1580-1589
    • Peppercorn, J.1    Herndon II, J.2    Kornblith, A.B.3
  • 34
    • 17944365031 scopus 로고    scopus 로고
    • Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support
    • Gulbrandsen N, Wisløff F, Brinch L, et al. Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support. Med Oncol 2001;18:65-77.
    • (2001) Med. Oncol. , vol.18 , pp. 65-77
    • Gulbrandsen, N.1    Wisløff, F.2    Brinch, L.3
  • 35
    • 0034992549 scopus 로고    scopus 로고
    • Longitudinal effects of highdose chemotherapy and autologous stem cell transplantation on quality of life in the treatment of metastatic breast cancer
    • Carlson LE, Koski T, Glü ck S. Longitudinal effects of highdose chemotherapy and autologous stem cell transplantation on quality of life in the treatment of metastatic breast cancer. Bone Marrow Transpl 2001;27:989-998.
    • (2001) Bone Marrow Transpl , vol.27 , pp. 989-998
    • Carlson, L.E.1    Koski, T.2    Ck, S.G.3
  • 36
    • 0033047988 scopus 로고    scopus 로고
    • Regimen related toxicity and non-relapse mortality with high-dose cyclophosphamide, carmustine (BCNU) and etopside (VP16-213) (CBV) and CBV plus cicplatine (CBVP) followed by autologous stem cell transplantation in patients with Hodgkin's disease
    • Reece DE, Nevill TJ, Sayegh A, et al. Regimen related toxicity and non-relapse mortality with high-dose cyclophosphamide, carmustine (BCNU) and etopside (VP16-213) (CBV) and CBV plus cicplatine (CBVP) followed by autologous stem cell transplantation in patients with Hodgkin's disease. Bone Marrow Transplant 1999;23:1131-1138.
    • (1999) Bone Marrow Transplant. , vol.23 , pp. 1131-1138
    • Reece, D.E.1    Nevill, T.J.2    Sayegh, A.3
  • 37
    • 0031002955 scopus 로고    scopus 로고
    • Idiopathic pneumonia syndrome after high-dose chemotherapy for relapsed Hodgkin's disease
    • Rubio C, Hill ME, Milan S, O'Brian M E R, Cunningham D. Idiopathic pneumonia syndrome after high-dose chemotherapy for relapsed Hodgkin's disease. Br J Cancer 1997;75:1044-1048.
    • (1997) Br. J. Cancer , vol.75 , pp. 1044-1048
    • Rubio, C.1    Hill, M.E.2    Milan, S.3    O'Brian, M.E.R.4    Cunningham, D.5
  • 38
    • 33748578003 scopus 로고    scopus 로고
    • Toxicity of high dose BCNU: How much is too much?
    • Van Besien K. Toxicity of high dose BCNU: how much is too much? Leuk Lymphoma 2006;47:1447-1448.
    • (2006) Leuk Lymphoma , vol.47 , pp. 1447-1448
    • Van Besien, K.1
  • 39
    • 53149141368 scopus 로고    scopus 로고
    • High-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma: The Seattle experience
    • Gopal AK, Metcalfe TL, Gooley TA, et al. High-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma: the Seattle experience. Cancer 2008;15;113(6):1344-1350.
    • (2008) Cancer , vol.15-113 , Issue.6 , pp. 1344-1350
    • Gopal, A.K.1    Metcalfe, T.L.2    Gooley, T.A.3
  • 40
    • 0036306357 scopus 로고    scopus 로고
    • Quality of life and rehabilitation in social and professional life after autologous stem cell transplantation
    • Hensel M, Egerer G, Schneeweiss A, Goldschmidt H, Ho AD. Quality of life and rehabilitation in social and professional life after autologous stem cell transplantation. Ann Oncology 2002;13:209-217.
    • (2002) Ann. Oncology , vol.13 , pp. 209-217
    • Hensel, M.1    Egerer, G.2    Schneeweiss, A.3    Goldschmidt, H.4    Ho, A.D.5
  • 41
    • 56049120865 scopus 로고    scopus 로고
    • Long-term effects of high-dose chemotherapy and radiation for relapsed and refractory Hodgkin's lymphoma
    • Goodman KA, Riedel E, Serrano V, et al. Long-term effects of high-dose chemotherapy and radiation for relapsed and refractory Hodgkin's lymphoma. J Clin Oncol 2008;26:5240-5247.
    • (2008) J. Clin. Oncol. , vol.26 , pp. 5240-5247
    • Goodman, K.A.1    Riedel, E.2    Serrano, V.3
  • 42
    • 33751002971 scopus 로고    scopus 로고
    • Better quality of life among 10-15 year survivors of Hodgkin's lymphoma compared to 5-9 year survivors: A population-based study
    • Mols F, Vingerhoets A J J M, Coebergh JW, et al. Better quality of life among 10-15 year survivors of Hodgkin's lymphoma compared to 5-9 year survivors: a population-based study. Eur J Cancer 2006;42:2794-2801.
    • (2006) Eur. J. Cancer , vol.42 , pp. 2794-2801
    • Mols, F.1    Vingerhoets, A.J.J.M.2    Coebergh, J.W.3
  • 43
    • 4544235084 scopus 로고    scopus 로고
    • Determinants of health-related quality of life in long-term survivors of Hodgkin's lymphoma
    • Wettergren L, Björkholm M, Axdorph U, Langius-Eklöf A. Determinants of health-related quality of life in long-term survivors of Hodgkin's lymphoma. Qual Life Res 2004;13:1369-1379.
    • (2004) Qual. Life Res. , vol.13 , pp. 1369-1379
    • Wettergren, L.1    Björkholm, M.2    Axdorph, U.3    Langius-Eklöf, A.4
  • 45
    • 0033042177 scopus 로고    scopus 로고
    • Retrospective assessment of quality of life and treatment outcome in patients with Hodgkin's disease from 1969 to 1994
    • Greil R, Holzner B, Kemmler G, et al. Retrospective assessment of quality of life and treatment outcome in patients with Hodgkin's disease from 1969 to 1994. Eur J Cancer 1999;35:698-706.
    • (1999) Eur. J. Cancer , vol.35 , pp. 698-706
    • Greil, R.1    Holzner, B.2    Kemmler, G.3
  • 46
    • 0029900062 scopus 로고    scopus 로고
    • Quality of life in survivors of Hodgkin's disease
    • Norum J, Wist EA. Quality of life in survivors of Hodgkin's disease. Qual Life Res 1996;5:367-374.
    • (1996) Qual. Life Res. , vol.5 , pp. 367-374
    • Norum, J.1    Wist, E.A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.